Table 4. Antibiotic resistance of G+ C bacteria (strains, n).
Antibiotics | Staphylococcus aureus (n = 30) | P | Coagulase negative staphylococcus (n = 131) | P | Enterococcus (n = 76) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Community-acquired (n = 9) | Nosocomial (n = 21) | Community-acquired (n = 56) | Nosocomial (n = 75) | Nosocomial (n = 76) | ||||||||
MRSA (n = 6) | MSSA (n = 3) | MRSA(n = 6) | MSSA (n = 15) | MRSCON (n = 40) | MSSCON (n = 16) | MRSCON (n = 61) | MSSCON (n = 14) | Faecalis (n = 52) | Faecium (n = 18) | |||
SBL | 6 | 3 | 6 | 15 | — | 40 | 9 | 61 | 7 | 0.56 | 22 | 5 |
Penicillin G | 6 | 3 | 6 | 15 | — | 40 | 9 | 61 | 7 | 0.56 | 48 | 5 |
Ceftriaxone | 6 | 0 | 6 | 0 | 0.05 | 40 | 0 | 61 | 0 | 0.18 | — | |
Cefoxitin | 6 | 0 | 6 | 0 | 0.05 | 40 | 0 | 61 | 0 | 0.18 | — | |
Amikacin | 3 | 0 | 4 | 2 | 0.79 | 17 | 0 | 5 | 0 | <0.01 | — | |
Levofloxacin | 4 | 2 | 6 | 2 | 0.15 | 11 | 2 | 34 | 0 | <0.01 | 39 | 5 |
SMZ | 2 | 0 | 2 | 1 | 0.59 | 20 | 6 | 35 | 1 | 0.86 | — | |
Clindamycin | 4 | 3 | 2 | 5 | <0.01 | 18 | 5 | 36 | 1 | 0.35 | — | |
Erythromycin | 3 | 2 | 2 | 10 | 0.94 | 25 | 11 | 54 | 7 | 0.03 | 41 | 11 |
Vancomycin | 0 | 0 | 0 | 1 | 0.51 | 0 | 0 | 0 | 0 | — | 0 | 0 |
Linezolid | 0 | 0 | 0 | 0 | — | 1 | 0 | 0 | 0 | 0.24 | 1 | 3 |
Teicoplanin | 0 | 0 | 0 | 0 | — | 0 | 0 | 2 | 0 | 0.22 | 1 | 0 |
Tetracycline | 3 | 0 | 4 | 2 | 0.79 | 10 | 4 | 15 | 3 | 0.90 | 48 | 11 |